PL3515454T3 - Krystaliczna polimorficzna postać 3-hydroksy-4,5-bis-benzyloksy- 6-benzyloksymetylo-2-fenylo-2-okso-2lambda5-[1,2]oksafosfinanu - Google Patents

Krystaliczna polimorficzna postać 3-hydroksy-4,5-bis-benzyloksy- 6-benzyloksymetylo-2-fenylo-2-okso-2lambda5-[1,2]oksafosfinanu

Info

Publication number
PL3515454T3
PL3515454T3 PL17776975T PL17776975T PL3515454T3 PL 3515454 T3 PL3515454 T3 PL 3515454T3 PL 17776975 T PL17776975 T PL 17776975T PL 17776975 T PL17776975 T PL 17776975T PL 3515454 T3 PL3515454 T3 PL 3515454T3
Authority
PL
Poland
Prior art keywords
2lambda5
oxaphosphinane
benzyloxymethyl
benzyloxy
oxo
Prior art date
Application number
PL17776975T
Other languages
English (en)
Inventor
Ludovic Clarion
Séverine LOISEAU
Pierric MARCHAND
Morgan PAUCHET
Original Assignee
Phost'in
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phost'in filed Critical Phost'in
Publication of PL3515454T3 publication Critical patent/PL3515454T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/657163Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom
    • C07F9/657172Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom the ring phosphorus atom and one oxygen atom being part of a (thio)phosphinic acid ester: (X = O, S)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/665Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
PL17776975T 2016-09-20 2017-09-19 Krystaliczna polimorficzna postać 3-hydroksy-4,5-bis-benzyloksy- 6-benzyloksymetylo-2-fenylo-2-okso-2lambda5-[1,2]oksafosfinanu PL3515454T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16306202.9A EP3295944A1 (en) 2016-09-20 2016-09-20 Crystalline polymorphic form of 3-hydroxy-4,5-bis-benzyloxy-6-benzyloxymethyl-2-phenyl-2-oxo-2lambda5-[1,2]oxaphosphinane
EP17776975.9A EP3515454B1 (en) 2016-09-20 2017-09-19 Crystalline polymorphic form of 3-hydroxy-4,5-bis-benzyloxy-6-benzyloxymethyl-2-phenyl-2-oxo-2lambda5-[1,2]oxaphosphinane
PCT/EP2017/073682 WO2018054925A1 (en) 2016-09-20 2017-09-19 Crystalline polymorphic form of 3-hydroxy-4,5-bis-benzyloxy-6-benzyloxymethyl-2-phenyl-2-oxo-2lambda5-[1,2]oxaphosphinane

Publications (1)

Publication Number Publication Date
PL3515454T3 true PL3515454T3 (pl) 2021-05-31

Family

ID=57130310

Family Applications (1)

Application Number Title Priority Date Filing Date
PL17776975T PL3515454T3 (pl) 2016-09-20 2017-09-19 Krystaliczna polimorficzna postać 3-hydroksy-4,5-bis-benzyloksy- 6-benzyloksymetylo-2-fenylo-2-okso-2lambda5-[1,2]oksafosfinanu

Country Status (12)

Country Link
US (1) US10597414B2 (pl)
EP (2) EP3295944A1 (pl)
JP (2) JP7235661B2 (pl)
KR (1) KR102566383B1 (pl)
CN (1) CN109843300B (pl)
AU (1) AU2017329753B2 (pl)
CA (1) CA3037093A1 (pl)
DK (1) DK3515454T3 (pl)
ES (1) ES2844425T3 (pl)
PL (1) PL3515454T3 (pl)
PT (1) PT3515454T (pl)
WO (1) WO2018054925A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202237093A (zh) 2021-01-13 2022-10-01 法商弗斯汀治療公司 治療纖維化疾病的方法
TW202404609A (zh) * 2022-05-20 2024-02-01 法商弗斯汀治療公司 雜環次膦酸化合物之劑量及投藥方案

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2170912B3 (en) * 2007-07-05 2022-06-15 Centre National De La Recherche Scientifique New phosphorus containing heterocyclic compounds, sugar analogues, and compositions having anti-cancer activity containing the same
FR3002451B1 (fr) 2013-02-25 2015-06-26 Centre Nat Rech Scient Heterocycles phosphores analogues de sucres a activite antimetastatique

Also Published As

Publication number Publication date
EP3515454B1 (en) 2020-11-11
EP3295944A1 (en) 2018-03-21
US10597414B2 (en) 2020-03-24
ES2844425T3 (es) 2021-07-22
KR102566383B1 (ko) 2023-08-11
CN109843300A (zh) 2019-06-04
US20190330252A1 (en) 2019-10-31
CN109843300B (zh) 2021-08-27
PT3515454T (pt) 2021-01-18
AU2017329753A1 (en) 2019-04-04
JP2022125284A (ja) 2022-08-26
JP2019529552A (ja) 2019-10-17
KR20190058518A (ko) 2019-05-29
EP3515454A1 (en) 2019-07-31
CA3037093A1 (en) 2018-03-29
WO2018054925A1 (en) 2018-03-29
JP7235661B2 (ja) 2023-03-08
AU2017329753B2 (en) 2022-05-19
DK3515454T3 (da) 2021-01-18

Similar Documents

Publication Publication Date Title
IL268852A (en) Crystalline forms of the 4-pyrimidinesulfamide derivative aprocitantane
IL271950A (en) Polymorphs of 5-fluoro-4-imino-3-methyl-1-tosyl-4,3-dihydropyrimidin-2-one
IL272697A (en) A polymorphic form of TG02
HK1258964A1 (zh) 用於製備1,3-苯並間二氧雜環戊烯雜環化合物的方法
IL271399A (en) Methods for the preparation of heterocyclic 3,1-benzodioxole compounds
ZA201608442B (en) Methods for the preparation of 1,3-benzodioxole heterocyclic compounds
HK1256825A1 (zh) 取代的5,6-二氫-6-苯基苯並[f]異喹啉-2-胺化合物的固體形式
PL3515454T3 (pl) Krystaliczna polimorficzna postać 3-hydroksy-4,5-bis-benzyloksy- 6-benzyloksymetylo-2-fenylo-2-okso-2lambda5-[1,2]oksafosfinanu
IL270961A (en) Crystalline form of N-butyldeoxygalactonogirimycin
GB201702947D0 (en) Novel compounds
GB201600977D0 (en) Novel crystalline form of picoxystrobin, method of preparing use of the same
GB201704789D0 (en) Crystalline compounds
GB201718561D0 (en) Novel compounds
GB201718563D0 (en) Novel compounds
GB201718564D0 (en) Novel compounds
GB201716131D0 (en) Novel compounds
GB201714699D0 (en) Novel compounds
GB201713082D0 (en) Novel compounds
GB201713083D0 (en) Novel compounds
GB201713085D0 (en) Novel compounds
GB201713076D0 (en) Novel compounds
GB201713079D0 (en) Novel Compounds
GB201711682D0 (en) Novel compounds
GB201711549D0 (en) Novel compounds
GB201710943D0 (en) Novel Compounds